The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9655979 B1

PDF
Full Text
Expired
Date of Patent:
May. 23, 2017

Filed:

Oct. 31, 2013
Applicant:

Johann Bauer, Salzburg, AT;

Inventors:

Johann Bauer, Salzburg, AT;

Christina Gruber, Bad Vigaun, AT;

Ulrich Koller, Neumarkt am Wallersee, AT;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); C12N 9/12 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A61K 48/00 (2013.01); C12N 9/1211 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/1138 (2013.01); C12N 2310/11 (2013.01); C12N 2310/3519 (2013.01); C12N 2320/33 (2013.01);
Abstract

The present invention pertains to a novel pre-mRNA trans-splicing molecule (RTM) comprising a binding region which is complementary to a pre mRNA of a tumor associated gene, and a coding domain which encodes for a suicide gene. Specific embodiments of the present invention relate to RTMs which mediate trans-splicing of a suicide gene, such as thymidine kinase from herpes simplex virus (HSV-tk), with the pre mRNA of the squamous cell carcinoma associated gene solute carrier organic anion transporter family member 1B3 (SLCO1B3). The invention provides RTMs which selectively kill cells expressing SLCO1B3 and which are thus useful in the treatment of cancer, specifically squamous cell carcinoma associated with epidermolysis bullosa. Also provided are methods, kits and pharmaceutical compositions relating to the RTMs in accordance to the invention.


Find Patent Forward Citations

Loading…